News

Home > News & Events > Oxford Research Validates EarlySign’s AI Platform for Identifying Risk of Colorectal Cancer

Oxford Research Validates EarlySign’s AI Platform for Identifying Risk of Colorectal Cancer

Oxford Research Validates EarlySign’s AI Platform for Identifying Risk of Colorectal Cancer
Date

October 3, 2017

Medial EarlySign, a developer of machine learning tools for data-driven medicine, announced the results of new research with Oxford University. The study provides further validation for Medial EarlySign’s ColonFlagTMalgorithm platform to identify individuals at risk of having colorectal cancer and support other approaches to early detection, including screening and active case finding.

 

The peer-reviewed study, Evaluation of a Prediction Model for Colorectal Cancer: Retrospective Analysis of 2.5 Million Patient Records, published in Cancer Medicine, evaluated Medial EarlySign’s risk stratification model for colorectal cancer. The UK research follows previous ColonFlagTM study results reported in the U.S. and Israel.

 

Download the study here

Download Oxford Study Evaluating MES Colorectal Cancer Prediction Model